Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.33), $0.06 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.